12
Participants
Start Date
April 12, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Rigosertib Oral Capsules / Rigosertib Intravenous
"Patients will take Rigosertib either as oral capsules or will get intravenous infusions depending on the needs of the patients.~Oral Capsules:~Patients will take oral Rigosertib continuously for a total of three weeks, every four week cycle (three weeks on, one week off drug) for up to 13 cycles. Patients will take 560 mg of oral Rigosertib (ie, 2 capsules of 280 mg) in the morning and in the afternoon, total of 1120mg/day.~Intravenous Infusions:~For IV treatment Rigosertib 1800 mg/24 hr is diluted in 0.9% sodium chloride for injection just prior to dosing and is administered as a 72-hr CIV infusion on days 1, 2, and 3 of a 2-week cycle for the first eight 2-week cycles, then on days 1, 2, and 3 of a 4-week cycle thereafter."
RECRUITING
EB House Austria/Dept. of Dermatology University Hospital, Salzburg
Prof. Johann Bauer
OTHER